Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Polymerase Chain Reaction (PCR) Market, by Technology
1.4.2 North America Polymerase Chain Reaction (PCR) Market, by Application
1.4.3 North America Polymerase Chain Reaction (PCR) Market, by Product
1.4.4 North America Polymerase Chain Reaction (PCR) Market, by End User
1.4.5 North America Polymerase Chain Reaction (PCR) Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.1.3 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Polymerase Chain Reaction Technologies Market by Technology
3.1 Introduction
3.1.1 North America Real-Time PCR Market by Country
3.1.2 North America Digital PCR Market by Country
3.1.3 North America Traditional PCR Market by Country
Chapter 4. North America Polymerase Chain Reaction Technologies Market by Application
4.1.1 North America Polymerase Chain Reaction Technologies in Forensics Market by Country
4.1.2 North America Polymerase Chain Reaction Technologies in Research Market by Country
4.1.3 North America Polymerase Chain Reaction Technologies in Clinical Market by Country
Chapter 5. North America Polymerase Chain Reaction Technologies Market by Product
5.1.1 North America Polymerase Chain Reaction Technologies Instruments Market by Country
5.1.2 North America Polymerase Chain Reaction Technologies Reagents & Consumables Market by Country
5.1.3 North America Polymerase Chain Reaction Technologies Software Market by Country
5.1.4 North America Polymerase Chain Reaction Technologies Services Market by Country
Chapter 6. North America Polymerase Chain Reaction Technologies Market by End User
6.1.1 North America Polymerase Chain Reaction Technologies in Biotech & Pharma Companies Market by Country
6.1.2 North America Polymerase Chain Reaction Technologies in Diagnostic Centers & Hospitals Market by Country
6.1.3 North America Polymerase Chain Reaction Technologies in Academic & Research Institutions Market by Country
Chapter 7. North America Polymerase Chain Reaction Technologies Market by Country
7.1 USA Polymerase Chain Reaction Technologies Market
7.1.1 USA Polymerase Chain Reaction Technologies Market by Technology
7.1.2 USA Polymerase Chain Reaction Technologies Market by Application
7.1.3 USA Polymerase Chain Reaction Technologies Market by Product
7.1.4 USA Polymerase Chain Reaction Technologies Market by End User
7.2 Canada Polymerase Chain Reaction Technologies Market
7.2.1 Canada Polymerase Chain Reaction Technologies Market by Technology
7.2.2 Canada Polymerase Chain Reaction Technologies Market by Application
7.2.3 Canada Polymerase Chain Reaction Technologies Market by Product
7.2.4 Canada Polymerase Chain Reaction Technologies Market by End User
7.3 Mexico Polymerase Chain Reaction Technologies Market
7.3.1 Mexico Polymerase Chain Reaction Technologies Market by Technology
7.3.2 Mexico Polymerase Chain Reaction Technologies Market by Application
7.3.3 Mexico Polymerase Chain Reaction Technologies Market by Product
7.3.4 Mexico Polymerase Chain Reaction Technologies Market by End User
7.4 Rest of North America Polymerase Chain Reaction Technologies Market
7.4.1 Rest of North America Polymerase Chain Reaction Technologies Market by Technology
7.4.2 Rest of North America Polymerase Chain Reaction Technologies Market by Application
7.4.3 Rest of North America Polymerase Chain Reaction Technologies Market by Product
7.4.4 Rest of North America Polymerase Chain Reaction Technologies Market by End User
Chapter 8. Company Profiles
8.1 F. Hoffmann-La Roche Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Revenue & Segment analysis
8.1.4 Research and Development
8.2 Bio-Rad Laboratories, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Thermo Fisher Scientific Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 bioMérieux SA
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.5 Takara Bio Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.6 Agilent Technologies
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Fluidigm Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.8 LGC Limited
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expense
8.9 Qiagen NV
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Expense
8.1 SYGNIS Pharma AG
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.